Boehringer Ingelheim Biopharmaceuticals China (BioChina), in collaboration with a customer, has successfully passed pre-approval inspections by the European Medicines Agency (EMA) and the U.S. Food and Drug Administration (FDA). As a result, the customer is now approved for the supply of the biopharmaceutical to the EU and US markets from product manufactured by Boehringer Ingelheim […]
New Delhi: The fire department rushed to the All India Institute of Medical Sciences (AIIMS), New Delhi after receiving a call reporting a fire in the surgery block of the institute but initial reports have turned out to be false. Responding swiftly to the call, DFS dispatched seven fire tenders to the location mentioned. However, upon […]
Ernakulam: Granting interim relief to the doctor accused of abetting his former fiance’s suicide, the Kerala High Court has allowed him to rejoin his post-graduate studies. This order was passed by a single-judge bench consisting of Justice Ziyad Rahman AA after considering the ‘irreversible damage’ caused by preventing the accused doctor from attending classes, Live Law […]
Mumbai: Global pharma major Lupin Limited has announced the launch of first generic version of Oracea (Doxycycline Capsules, 40 mg), in the United States, after having received an approval from the United States Food and Drug Administration (U.S. FDA). Read also: Lupin gets USFDA nod for generic equivalent of Oracea Capsules Doxycycline Capsules, 40 mg is […]
South Korea: Adjunctive pioglitazone therapy in type 2 diabetes mellitus (T2DM) inadequately controlled with dapagliflozin and metformin yielded considerable metabolic benefits, glycemic improvement, and a low hypoglycemia risk, a phase 3 trial showed. The findings were published online in Diabetes, Obesity and Metabolism on February 29, 2024. The researchers, however, suggest weighing its advantages against […]
China: A two-sample Mendelian randomization (MR) study provides genetic evidence supporting the anti-inflammatory effects of sodium-glucose cotransporter 2 (SGLT-2) inhibitors and their beneficial impact in reducing heart failure (HF) risk. CXCL10 emerged as a potential mediator, offering a novel intervention pathway for the treatment of heart failure. The findings were published online in Cardiovascular Diabetology […]
Withdrawing aspirin one month after percutaneous coronary intervention (PCI) in high-risk heart patients and keeping them on ticagrelor alone safely improves outcomes and reduces major bleeding by more than half when compared to patients taking aspirin and ticagrelor combined (also known as dual antiplatelet therapy or DAPT), which is the current standard of care. These […]
Brazil: A recent study has revealed that adjuvant hyperbaric oxygen therapy (HBOT) may provide some benefits in treating pyoderma gangrenosum patients, particularly those with multiple comorbidities precluding them from receiving more traditional treatments. The study findings were published online in the Journal of the European Academy of Dermatology and Venereology on March 20, 2024 “After […]
Hypertriglyceridemia, or high levels of lipids (fats) in the blood, increases the risk of heart attack, stroke and acute pancreatitis. Currently available medications, including statins, ezetimibe, fibrates and prescription omega 3 fatty acids, typically lower triglyceride levels by anywhere from below 10% to up to 40%. These therapies help, but they are not enough to […]
USA: A recent study published in JAMA Surgery reports US liver transplant outcomes after normothermic regional perfusion (NRP) versus standard super rapid recovery. The findings suggest that NRP improves controlled donation after circulatory death (DCD) liver allograft outcomes and holds the potential to increase DCD organ use. “The multicenter cohort study comprisng136 livers recovered with […]